Historical Valuation
Adapthealth Corp (AHCO) is now in the Fair zone, suggesting that its current forward PE ratio of 11.26 is considered Fairly compared with the five-year average of 14.22. The fair price of Adapthealth Corp (AHCO) is between 8.56 to 16.60 according to relative valuation methord.
Relative Value
Fair Zone
8.56-16.60
Current Price：10.49
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Adapthealth Corp (AHCO) has a current Price-to-Book (P/B) ratio of 0.79. Compared to its 3-year average P/B ratio of 0.81 , the current P/B ratio is approximately -2.53% higher. Relative to its 5-year average P/B ratio of 1.34, the current P/B ratio is about -40.80% higher. Adapthealth Corp (AHCO) has a Forward Free Cash Flow (FCF) yield of approximately 16.64%. Compared to its 3-year average FCF yield of 10.66%, the current FCF yield is approximately 56.11% lower. Relative to its 5-year average FCF yield of 7.52% , the current FCF yield is about 121.21% lower.
P/B
Median3y
0.81
Median5y
1.34
FCF Yield
Median3y
10.66
Median5y
7.52
Competitors Valuation Multiple
AI Analysis for AHCO
The average P/S ratio for AHCO competitors is 0.90, providing a benchmark for relative valuation. Adapthealth Corp Corp (AHCO.O) exhibits a P/S ratio of 0.38, which is -57.42% above the industry average. Given its robust revenue growth of 1.79%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for AHCO
1Y
3Y
5Y
Market capitalization of AHCO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AHCO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AHCO currently overvalued or undervalued?
Adapthealth Corp (AHCO) is now in the Fair zone, suggesting that its current forward PE ratio of 11.26 is considered Fairly compared with the five-year average of 14.22. The fair price of Adapthealth Corp (AHCO) is between 8.56 to 16.60 according to relative valuation methord.
What is Adapthealth Corp (AHCO) fair value?
AHCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Adapthealth Corp (AHCO) is between 8.56 to 16.60 according to relative valuation methord.
How does AHCO's valuation metrics compare to the industry average?
The average P/S ratio for AHCO's competitors is 0.90, providing a benchmark for relative valuation. Adapthealth Corp Corp (AHCO) exhibits a P/S ratio of 0.38, which is -57.42% above the industry average. Given its robust revenue growth of 1.79%, this premium appears unsustainable.
What is the current P/B ratio for Adapthealth Corp (AHCO) as of Jan 10 2026?
As of Jan 10 2026, Adapthealth Corp (AHCO) has a P/B ratio of 0.79. This indicates that the market values AHCO at 0.79 times its book value.
What is the current FCF Yield for Adapthealth Corp (AHCO) as of Jan 10 2026?
As of Jan 10 2026, Adapthealth Corp (AHCO) has a FCF Yield of 16.64%. This means that for every dollar of Adapthealth Corp’s market capitalization, the company generates 16.64 cents in free cash flow.
What is the current Forward P/E ratio for Adapthealth Corp (AHCO) as of Jan 10 2026?
As of Jan 10 2026, Adapthealth Corp (AHCO) has a Forward P/E ratio of 11.26. This means the market is willing to pay $11.26 for every dollar of Adapthealth Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Adapthealth Corp (AHCO) as of Jan 10 2026?
As of Jan 10 2026, Adapthealth Corp (AHCO) has a Forward P/S ratio of 0.38. This means the market is valuing AHCO at $0.38 for every dollar of expected revenue over the next 12 months.